Home/Filings/4/0001209191-20-059167
4//SEC Filing

Wenqing Yao 4

Accession 0001209191-20-059167

CIK 0000879169other

Filed

Nov 17, 7:00 PM ET

Accepted

Nov 18, 5:03 PM ET

Size

6.0 KB

Accession

0001209191-20-059167

Insider Transaction Report

Form 4
Period: 2020-11-16
Wenqing Yao
Ex VP Discovery Medicinal Chem
Transactions
  • Award

    Common Stock

    2020-11-16+1,232156,851 total
Footnotes (2)
  • [F1]Represents shares of common stock underlying performance shares earned upon the interim achievement of performance criteria determined to be satisfied on November 16, 2020. The earned shares will vest on the third anniversary of the July 2, 2020 grant date, subject to the Reporting Persons continued service with the Issuer. Each performance share represents the right to receive one or more shares of common stock based on, and subject to, the achievement of specified financial and development performance criteria determined by the Issuers Compensation Committee in January 2020 as set forth in the Performance Share Award Agreement. The number of shares of common stock that the Reporting Person is entitled to receive over the three year performance period ranges from 0% to 175% of the number of performance shares awarded.
  • [F2]Including the Performance Stock Units earned on November 16, 2020, this includes an aggregate of 96,700 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.

Issuer

INCYTE CORP

CIK 0000879169

Entity typeother

Related Parties

1
  • filerCIK 0001624033

Filing Metadata

Form type
4
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 5:03 PM ET
Size
6.0 KB